Cost Savings With Intramuscular Anticholinergics

View This PDF

NB: This article is only available as a PDF.

Letter to the Editor

Sir: With the advent of atypical antipsychotics, novel anticonvulsant agents, and selective serotonin reuptake inhibitors, the pharmacotherapy of psychiatric disorders has changed tremendously in the last decade. Although these newer medications are generally better tolerated, and, in some cases, lessen associated costs of more frequent hospitalizations, they have greatly impacted hospital pharmacy budgets. With few of these newer medications available generically, there is little opportunity to decrease medication costs except in interventions such as tablet splitting.

J Clin Psychiatry 2001;62(4):295 [letter]